Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]

PaperCitations, authors & open-access status

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686] is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 29 citations, 2022 year and gold oa status.

29
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Stephen Apple
Author
PLoS ONE
Journal
Amyotrophic Lateral Sclerosis Research
Topic
Amyotrophic Lateral Sclerosis Research
Topic
Neurogenetic and Muscular Disorders Research
Topic
Genetic Neurodegenerative Diseases
Topic
470M+ articles · free account